Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE)

Trial Phase 1 Active, not recruiting Oct. 27, 2025

Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS

Trial Phase 1 Active, not recruiting Oct. 27, 2025

Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation

Trial N/A Completed Oct. 26, 2025

rTMS Treatment of Dysphagia in Parkinson's Patients

Trial N/A Completed Oct. 26, 2025

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

Trial N/A Recruiting Oct. 22, 2025

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Trial N/A Recruiting Oct. 21, 2025

Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease

Trial N/A Enrolling by invitation Oct. 21, 2025

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Trial Phase 2 Terminated Oct. 20, 2025

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

Trial Phase 2 Not yet recruiting Oct. 14, 2025

Motor Training in PD

Trial N/A Completed Oct. 14, 2025

Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

Trial N/A Recruiting Oct. 14, 2025

Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback

Trial N/A Completed Oct. 14, 2025

Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study

Trial N/A Recruiting Oct. 13, 2025

Personal KinetiGraph® Clinical Validation Study

Trial N/A Completed Oct. 13, 2025

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

Trial Phase 2 Recruiting Oct. 13, 2025

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Trial Phase 1 Recruiting Oct. 13, 2025

Combining Aerobic Exercise and Virtual Reality for Cognitive-motor Rehabilitation in PD

Trial N/A Completed Oct. 8, 2025

Novel DBS Device in Parkinson's Disease

Trial N/A Completed Oct. 8, 2025

Freezing in Parkinson's Disease

Trial N/A Completed Oct. 7, 2025

Molecular and Functional Imaging in Monogenic PD.

Trial N/A Recruiting Oct. 6, 2025